
As professionals working closely with medical device manufacturers, we see a clear trend: smart insulin recorders and connected insulin pens are becoming core tools in diabetes management.
These devices don’t just log injections—they synchronize data, enable clinical insights, and support regulatory-grade accuracy. At the heart of all this functionality lies a component that is often underestimated but critically important:
the smart insulin recorder battery.
A battery failure does not simply mean downtime—it risks data loss, inaccurate dosing records, and regulatory non-compliance. That’s why battery selection for insulin recording devices must be approached as a medical engineering decision, not a consumer electronics afterthought.

A smart insulin recorder is a compact electronic module integrated into or attached to an insulin pen or injector. Its primary functions include:
Recording injection time and dosage
Storing historical insulin usage data
Transmitting data via Bluetooth or NFC
Synchronizing with mobile apps or cloud platforms
Most smart insulin recorders are classified as Class I or Class II medical devices, depending on region and function, which directly impacts battery requirements.
From our experience supplying batteries for medical OEMs, insulin recorder batteries must meet five non-negotiable criteria:
Smart insulin recorders typically operate in deep sleep mode over 95% of the time, waking only to:
Detect injection motion
Log dosage data
Transmit data periodically
The battery must support stable voltage at microamp-level current draw, something many standard consumer batteries fail to do reliably.
Most insulin recorders are sealed, non-user-replaceable devices. Battery life expectations include:
| Device Type | Expected Battery Life |
|---|---|
| Basic insulin recorder | 12–18 months |
| Bluetooth-enabled recorder | 18–24 months |
| Cloud-connected recorder | 24–36 months |
A short battery lifespan increases:
Warranty claims
Device returns
Regulatory risk

Because insulin recorders are used daily, often by elderly or pediatric patients, the battery must offer:
No leakage risk
Excellent thermal stability
Resistance to over-discharge
Lithium chemistry selection is critical here.
Smart insulin recorders demand:
Thin profiles
Custom shapes (curved, ultra-slim)
Lightweight design (<5g battery mass)
This rules out many standard cylindrical cells.
Battery materials and structure must support compliance with:
IEC 62133
UN38.3
ISO 10993 (biocompatibility, when applicable)
FDA / MDR technical documentation

Pros:
Extremely low self-discharge
Long shelf life (5–10 years)
Simple power management
Cons:
Limited current output
Not rechargeable
Typical use case:
Basic insulin recorders without wireless communication.
Pros:
Ultra-thin and customizable
Supports Bluetooth transmission
Rechargeable design
Cons:
Requires protection circuitry
Shorter total lifecycle vs primary lithium
Typical use case:
Smart insulin pens and Bluetooth-enabled recorders.
AS401230 3.7V 120mAh Lithium Polymer Battery with UL1642/CB/UN38.3/CE/KC certification For use with smart insulin recorders.
Often overlooked but increasingly popular in medical wearables.
Key advantages:
High energy density
Excellent voltage stability
Strong safety profile
Below is a simplified power consumption breakdown based on industry averages:
| Function | Current Draw | Duration |
|---|---|---|
| Sleep mode | 2–5 µA | 23+ hours/day |
| Injection detection | 3–8 mA | <1 second |
| Bluetooth transmission | 10–15 mA | <5 seconds/day |
Insight:
Battery optimization is less about “large capacity” and more about efficient power management.
From a compliance standpoint, insulin recorder batteries must address:
Overcharge protection
Over-discharge protection
Short-circuit prevention
Mechanical integrity under daily handling
In our projects, we often integrate:
Dual-layer protection circuits
Medical-grade insulation materials
Laser-welded tabs for reliability

Off-the-shelf batteries rarely fit medical device constraints perfectly.
Custom battery solutions are recommended when:
Device thickness <5 mm
Non-rectangular housing
Specific voltage cut-off requirements
Long standby + burst transmission profile
| Custom Parameter | Available Options |
|---|---|
| Shape | Rectangular, curved, L-shape |
| Thickness | As thin as 2.5 mm |
| Capacity | 20 mAh – 500 mAh |
| Connector | FPC, JST, welded tabs |
| Protection | Single / dual IC |

Before mass production, insulin recorder batteries typically undergo:
Cycle life testing
Shelf aging simulation
Temperature stress tests (-20°C to +60°C)
Transportation simulation (UN38.3)
This testing data is often included in technical files for FDA or MDR submissions.
FDA 21 CFR Part 820
Battery documentation included in Design History File (DHF)
MDR (EU 2017/745)
Battery traceability and material disclosure required
UN38.3 certification mandatory
A smart insulin recorder is only as reliable as its power source.
Battery-related failures can lead to:
Missing insulin dose records
App synchronization errors
Loss of patient confidence
For chronic disease management, trust equals adherence, and adherence starts with device reliability.
Most smart insulin recorders use lithium primary coin cells or ultra-thin lithium polymer batteries, depending on whether wireless connectivity is required.
Battery life typically ranges from 12 to 36 months, depending on transmission frequency, sensor activity, and power management design.
Most are sealed and non-user-replaceable to maintain device integrity and regulatory compliance.
Yes. Batteries must support device compliance with IEC 62133, UN38.3, and relevant FDA or MDR requirements.